The institute is asking lawmakers to change provisions on SALT deductions for pass-through entities, contingency fees for tax prep, and business loss carryforwards.
Gen AI is now capable of producing fake documents realistic enough to fool automated systems, creating new opportunities for fraud and new challenges for those trying to prevent it.
The ruling could present a new obstacle for Republicans who are relying on the revenue to help offset the cost of a $4 trillion tax cut moving through Congress.
Although the FDA has rejected Stealth’s new drug application for Barth syndrome candidate elamipretide, the agency identified a potential accelerated approval pathway. The company has pared down its staff to conserve resources to fund a potential resubmission.